Depressive Disorders in Survivors of COVID-19: Clinical Observation
https://doi.org/10.31550/1727-2378-2023-22-6-44-48
Abstract
Aim: To present a case study of patient S., who came to the psychiatric clinic because of a depressive episode after COVID-19 infection.
Key points. COVID-19 can cause various complications that last several weeks to several months after initial recovery. Young, healthy individuals can have post-COVID disorders even after mild COVID-19. Depression and anxiety disorders are among the consequences of past coronavirus infection.
Conclusion. This case study demonstrates that post-COVID patients develop persistent depres-sive disorders causing patient maladaptation and requiring drug therapy.
About the Authors
D. A. Golovkina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
11 Rossolimo Str., build. 11, Moscow, 119021
A. K. Vasyuta
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
11 Rossolimo Str., build. 11, Moscow, 119021
Yu. G. Tikhonova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
11 Rossolimo Str., build. 11, Moscow, 119021
T. I. Avdeeva
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
11 Rossolimo Str., build. 11, Moscow, 119021
M. A. Kinkulkina
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation
Russian Federation
11 Rossolimo Str., build. 11, Moscow, 119021
References
1. Datta S.D., Talwar A., Lee J.T. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251–2. DOI: 10.1001/jama.2020.22717
2. Greenhalgh T., Knight M., A'Court C., Buxton M. et al. Management of post-acute COVID-19 in primary care. BMJ. 2020;370:m3026. DOI: 10.1136/bmj.m3026
3. Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D. et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect. Dis. 2021;8(10):ofab440. DOI: 10.1093/ofid/ofab440
4. Hampshire A., Trender W., Chamberlain S.R., Jolly A.E. et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044. DOI: 10.1016/j.eclinm.2021.101044
5. Hellmuth J., Barnett T.A., Asken B.M., Kelly J.D. et al. Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients. J. Neurovirol. 2021;27(1):191–5. DOI: 10.1007/s13365- 021-00954-4
6. Mazza M.G., Palladini M., Poletti S., Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681–702. DOI: 10.1007/s40263-022-00931-3
7. Theoharides T.C., Cholevas C., Polyzoidis K., Politis A. Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47(2):232–41. DOI: 10.1002/biof.1726 8. Iadecola C., Anrather J., Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183(1):16–27.e1. DOI: 10.1016/j.cell.2020.08.028
8. Wu Y., Xu X., Chen Z., Duan J. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18–22. DOI: 10.1016/j.bbi.2020.03.031
9. Ali Awan H., Najmuddin Diwan M., Aamir A., Ali M. et al. SARS-CoV-2 and the brain: what do we know about the causality of 'cognitive COVID? J. Clin. Med. 2021;10(15):3441. DOI: 10.3390/jcm10153441
10. Jha N.K., Ojha S., Jha S.K., Dureja H. et al. Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations. J. Mol. Neurosci. 2021;71(11): 2192–209. DOI: 10.1007/s12031-020-01767-6
11. Muccioli L., Pensato U., Cani I., Guarino M. et al. COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation. Ann. Neurol. 2020;88(4):860–1. DOI: 10.1002/ana.25855
12. Altena E., Baglioni C., Espie C.A., Ellis J. et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: practical recommendations from a task force of the European CBT-I Academy. J. Sleep Res. 2020;29(4):e13052. DOI: 10.1111/jsr.13052
13. Gunaratne P., Lloyd A.R., Vollmer-Conna U. Mood disturbance after infection. Aust. N. Z. J. Psychiatry. 2013;47(12:1152–64. DOI: 10.1177/0004867413503718
14. Okusaga O., Yolken R.H., Langenberg P., Lapidus M. et al. Association of seropositivity for influenza and coronaviruses with history of mood disorders and suicide attempts. J. Affect. Disord. 2011;130(1– 2):220–5. DOI: 10.1016/j.jad.2010.09.029
15. Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95– 8. DOI: 10.1093/qjmed/hcab007
16. Vindegaard N., Benros M.E. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav. Immun. 2020;89:531–42. DOI: 10.1016/j.bbi.2020.05.048
17. Chew N.W.S., Lee G.K.H., Tan B.Y.Q., Jing M. et al. A multinational, multicentre study on the psychological outcomes and associated physical symptoms amongst healthcare workers during COVID-19 outbreak. Brain Behav. Immun. 2020;88:559–65. DOI: 10.1016/j.bbi.2020.04.049
18. Grover S., Sahoo S., Mishra E., Gill K.S. et al. Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection. Asian J. Psychiatr. 2021;64:102815. DOI: 10.1016/j.ajp.2021.102815
19. Bonazza F., Borghi L., di San Marco E.C., Piscopo K. et al. Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients. Res. Psychother. 2021;23(3):491. DOI: 10.4081/ripppo.2020.491
20. Castelli L., Di Tella M., Benfante A., Romeo A. The spread of COVID-19 in the Italian population: anxiety, depression, and post-traumatic stress symptoms. Can. J. Psychiatry. 2020;65(10):731–2. DOI: 10.1177/0706743720938598
21. Huang L., Yao Q., Gu X., Wang Q. et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747–58. DOI: 10.1016/S0140-6736(21)01755-4
22. Efstathiou V., Stefanou M.I., Demetriou M., Siafakas N. et al. Long COVID and neuropsychiatric manifestations (review). Exp. Ther. Med. 2022;23(5):363. DOI: 10.3892/etm.2022.11290
23. Taquet M., Dercon Q., Luciano S., Geddes J.R. et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. DOI: 10.1371/journal.pmed.1003773
24. Rousseau A.-F., Minguet P., Colson C., Kellens I. et al. Post-intensive care syndrome after a critical COVID-19: cohort study from a Belgian follow-up clinic. Ann. Intensive Care. 2021;11(1):118. DOI: 10.1186/s13613-021-00910-9
25. Wu K.K., Lee D., Sze A.M., Ng V.N. et al. Posttraumatic stress, anxiety, and depression in COVID-19 survivors. East Asian Arch. Psychiatry. 2022;32(1):5–10. DOI: 10.12809/eaap2176
26. Logue J.K., Franko N.M., McCulloch D.J., McDonald D. et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 2021;4(2):e210830. DOI: 10.1001/jamanetworkopen.2021.0830
27. Vanderlind W.M., Rabinovitz B.B., Miao I.Y., Oberlin L.E. et al. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr. Opin. Psychiatry. 2021;34(4):420–33. DOI: 10.1097/YCO.0000000000000713
28. Vertogradova O.P., Dikov S.Yu. Somatic-autonomic disturbances in different types of depression. S.S. Korsakov Journal of Neurology and Psychiatry. 2011;111(7):18–24. (in Russian)
29. Bisaccia G., Ricci F., Recce V., Serio A. et al. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: what do we know? J. Cardiovasc. Dev. Dis. 2021;8(11):156. DOI: 10.3390/jcdd8110156
30. Shimohata T. Neuro-COVID-19. Clin. Exp. Neuroimmunol. 2022;13(1):17–23. DOI: 10.1111/cen3.12676
31. Sivolap Yu.P. Panic disorder: clinical phenomena and treatment options. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(4):112–16. (in Russian). DOI: 10.17116/jnevro20171174112-116
32. Sorokin S.A. Apathetic disorders in the structure of endogenous depression. Psychiatry. 2015;1:33–8. (in Russian)
33. Smulevich A.B. Masked depressions. Mental Disorders in General Medicine. 2012;3:4–7. (in Russian)
34. Smulevich A.B., Dubnitskaya E.B. Depression in the general medical network. In: Smulevich A.B., ed. Mental disorders in clinical practice. M.: MEDpress-inform; 2011: 334–60. (in Russian)
Review
For citations:
Golovkina D.A., Vasyuta A.K., Tikhonova Yu.G., Avdeeva T.I., Kinkulkina M.A. Depressive Disorders in Survivors of COVID-19: Clinical Observation. Title. 2023;22(6):44-48. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-6-44-48
Views:
25
Email this article 